AAP News Vol. 13 No. 6 June 1997, p. 5
© 1997 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tharp, M.
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Pediatric drug labeling bill introduced

Marjorie Tharp

The day when pediatricians can prescribe medicine to a patient knowing exactly the drug's safety, efficacy and dosage may come sooner rather than later with the introduction of the Better Pharmaceuticals for Children Act.

The bill (S.713) would grant six months of market exclusivity for drugs that have undergone pediatric studies at the request of the Secretary of the U.S. Department of Health and Human Services (HHS).

"We put labels on the food they eat and the television they watch," said Sen. Christopher Dodd (D-Conn.), who sponsored the bill with Sen. Mike DeWine (R-Ohio). "We shouldn't be guessing about the medicine we give them."